Arquivos de Neuro-Psiquiatria (Jun 2021)

Cannabinoids in Neurology - Position paper from Scientific Departments from Brazilian Academy of Neurology

  • Sonia Maria Dozzi BRUCKI,
  • Tarso ADONI,
  • Carlos Mauricio Oliveira ALMEIDA,
  • Daniel Ciampi de ANDRADE,
  • Renato ANGHINAH,
  • Luciana Mendonça BARBOSA,
  • Rodrigo BAZAN,
  • Alzira Alves de Siqueira CARVALHO,
  • William CARVALHO,
  • Paulo Pereira CHRISTO,
  • Marcus Della COLETTA,
  • Adriana Bastos CONFORTO,
  • Ylmar CORREA-NETO,
  • Eliasz ENGELHARDT,
  • Marcondes Cavalcante FRANÇA JUNIOR,
  • Clelia FRANCO,
  • Felipe VON GLEHN,
  • Helio Rodrigues GOMES,
  • Caroline Gomes de Barros HOULY,
  • Alexandre Ottoni KAUP,
  • Fernando KOWACS,
  • Aline KANASHIRO,
  • Victor Gonçalves LOPES,
  • Débora MAIA,
  • Maria MANREZA,
  • Alberto Rolim Muro MARTINEZ,
  • Sandra Cristina Gonçalves MARTINEZ,
  • Saulo Nardy NADER,
  • Luciana de Oliveira NEVES,
  • Ivan Hideyo OKAMOTO,
  • Rogério Adas Ayres de OLIVEIRA,
  • Fabiano de Melo PEIXOTO,
  • Cristiana Borges PEREIRA,
  • Roberta Arb SABA,
  • Leticia Pereira de Brito SAMPAIO,
  • Lucas Porcello SCHILLING,
  • Marcus Tulius Teixeira SILVA,
  • Emanuelle Roberta SILVA,
  • Jerusa SMID,
  • Cristiane Nascimento SOARES,
  • Manoel SOBREIRA-NETO,
  • Nise Alessandra de Carvalho SOUSA,
  • Leonardo Cruz de SOUZA,
  • Hélio Afonso Ghizoni TEIVE,
  • Vera Cristina TERRA,
  • Matheus VALE,
  • Vitor Mendes Grise VIEIRA,
  • Edmar ZANOTELI,
  • Gilmar PRADO

DOI
https://doi.org/10.1590/0004-282x-anp-2020-0432
Journal volume & issue
Vol. 79, no. 4
pp. 354 – 369

Abstract

Read online

ABSTRACT Cannabinoids comprehend endocannabinoids, phytocannabinoids, and synthetic cannabinoids, with actions both in the central and peripherical nervous systems. A considerable amount of publications have been made in recent years, although cannabis has been known for over a thousand years. Scientific Departments from the Brazilian Academy of Neurology described evidence for medical use in their areas. Literature is constantly changing, and possible new evidence can emerge in the next days or months. Prescription of these substances must be discussed with patients and their families, with knowledge about adverse events and their efficacy.

Keywords